https://ir.pelthos.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/_75f87c490a70454dbc03829ddee17a08/chromocell/files/theme/images/logo-sm.png Equisolve Investor Relations Suite https://ir.pelthos.com/news-events/press-releases/detail/60/pelthos-therapeutics-added-to-russell-3000e-growth-benchmark-russell-microcap-and-russell-microcap-growth-benchmark-indexes Tue, 30 Jun 26 16:15:00 -0400 https://ir.pelthos.com/news-events/press-releases/detail/60/pelthos-therapeutics-added-to-russell-3000e-growth-benchmark-russell-microcap-and-russell-microcap-growth-benchmark-indexes https://ir.pelthos.com/news-events/press-releases/detail/59/pelthos-therapeutics-to-participate-in-2026-jefferies-global-healthcare-conference Thu, 28 May 26 17:00:00 -0400 https://ir.pelthos.com/news-events/press-releases/detail/59/pelthos-therapeutics-to-participate-in-2026-jefferies-global-healthcare-conference https://ir.pelthos.com/news-events/press-releases/detail/58/pelthos-therapeutics-announces-first-quarter-2026-financial-results Thu, 14 May 26 07:00:00 -0400 https://ir.pelthos.com/news-events/press-releases/detail/58/pelthos-therapeutics-announces-first-quarter-2026-financial-results https://ir.pelthos.com/news-events/press-releases/detail/57/pelthos-therapeutics-to-report-first-quarter-2026-financial-results-on-may-14-2026 Fri, 01 May 26 08:30:00 -0400 https://ir.pelthos.com/news-events/press-releases/detail/57/pelthos-therapeutics-to-report-first-quarter-2026-financial-results-on-may-14-2026 https://ir.pelthos.com/news-events/press-releases/detail/56/pelthos-therapeutics-to-participate-in-piper-sandler-spring-biopharma-symposium Tue, 14 Apr 26 08:30:00 -0400 https://ir.pelthos.com/news-events/press-releases/detail/56/pelthos-therapeutics-to-participate-in-piper-sandler-spring-biopharma-symposium https://ir.pelthos.com/news-events/press-releases/detail/55/pelthos-therapeutics-announces-cfo-transition Fri, 10 Apr 26 17:00:00 -0400 https://ir.pelthos.com/news-events/press-releases/detail/55/pelthos-therapeutics-announces-cfo-transition https://ir.pelthos.com/news-events/press-releases/detail/54/pelthos-therapeutics-announces-first-patient-dosed-in-phase-1b2a-clinical-trial-of-ct2000-in-eye-pain Tue, 31 Mar 26 08:30:00 -0400 https://ir.pelthos.com/news-events/press-releases/detail/54/pelthos-therapeutics-announces-first-patient-dosed-in-phase-1b2a-clinical-trial-of-ct2000-in-eye-pain https://ir.pelthos.com/news-events/press-releases/detail/53/pelthos-therapeutics-announces-fourth-quarter-and-full-year-2025-financial-results Thu, 19 Mar 26 06:30:00 -0400 https://ir.pelthos.com/news-events/press-releases/detail/53/pelthos-therapeutics-announces-fourth-quarter-and-full-year-2025-financial-results https://ir.pelthos.com/news-events/press-releases/detail/52/pelthos-therapeutics-to-present-at-38th-annual-roth-conference Thu, 12 Mar 26 08:30:00 -0400 https://ir.pelthos.com/news-events/press-releases/detail/52/pelthos-therapeutics-to-present-at-38th-annual-roth-conference https://ir.pelthos.com/news-events/press-releases/detail/51/pelthos-therapeutics-to-report-fourth-quarter-and-full-year-2025-financial-results-on-march-19-2026 Mon, 09 Mar 26 08:30:00 -0400 https://ir.pelthos.com/news-events/press-releases/detail/51/pelthos-therapeutics-to-report-fourth-quarter-and-full-year-2025-financial-results-on-march-19-2026